Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Los analistas estiman Beneficio por acción (EPS) de $-36.70 y ingresos de $0.00B para el próximo año fiscal.
Historial de Beneficio por acción (EPS): 2024: real $-6.38 vs est $-36.70 (superó +82.6%). 2025: real $-20.00 vs est $-12.50 (no alcanzó -60%). Precisión del analista: 0%.
Estimaciones de BPA — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.38
vs Est –$36.70
▲ 475.2% off
2025
Actual –$20.00
vs Est –$12.50
▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Estimaciones de Ingresos — INBS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.004B
▼ 35.0% off
2025
Actual $0.003B
vs Est $0.012B
▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
